These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18300752)

  • 1. New molecular concepts and targets in acute myeloid leukemia.
    Buzzai M; Licht JD
    Curr Opin Hematol; 2008 Mar; 15(2):82-7. PubMed ID: 18300752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.
    Amadori S; Stasi R
    Curr Opin Hematol; 2008 Mar; 15(2):95-100. PubMed ID: 18300754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy.
    Tsiftsoglou AS; Bonovolias ID; Tsiftsoglou SA
    Pharmacol Ther; 2009 Jun; 122(3):264-80. PubMed ID: 19306896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies reactive with acute myelogenous leukemia cells.
    Linker-Israeli M; Billing RJ; Foon KA; Terasaki PI
    J Immunol; 1981 Dec; 127(6):2473-7. PubMed ID: 7028873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells.
    Mahlknecht U; Schönbein C
    Haematologica; 2008 Mar; 93(3):443-6. PubMed ID: 18268283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia stem cells.
    Dick JE
    Ann N Y Acad Sci; 2005 Jun; 1044():1-5. PubMed ID: 15958691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication of leukemia stem cells as a new goal of therapy in leukemia.
    Ravandi F; Estrov Z
    Clin Cancer Res; 2006 Jan; 12(2):340-4. PubMed ID: 16428470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hox genes: from leukemia to hematopoietic stem cell expansion.
    Abramovich C; Pineault N; Ohta H; Humphries RK
    Ann N Y Acad Sci; 2005 Jun; 1044():109-16. PubMed ID: 15958703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms controlling pathogenesis and survival of leukemic stem cells.
    Jordan CT; Guzman ML
    Oncogene; 2004 Sep; 23(43):7178-87. PubMed ID: 15378078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early gene expression of acute myeloid leukemia in response to chemotherapy.
    Anensen N; Øyan AM; Huseby S; Kalland KH; Bruserud Ø; Gjertsen BT
    Expert Rev Anticancer Ther; 2007 May; 7(5):741-51. PubMed ID: 17492937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute myeloid leukemia by directly targeting both leukemia stem cells and oncogenic molecule with specific scFv-immunolipoplexes as a deliverer.
    Wang GP; Qi ZH; Chen FP
    Med Hypotheses; 2008; 70(1):122-7. PubMed ID: 17566667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis: myeloid-restricted hematopoietic stem cells with self-renewal capacity may be the transformation site in acute myeloid leukemia.
    Satoh C; Ogata K
    Leuk Res; 2006 Apr; 30(4):491-5. PubMed ID: 16183117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathobiology of acute myeloid leukemia].
    Christ O; Feuring-Buske M; Hiddemann W; Buske C
    Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
    Mrózek K; Döhner H; Bloomfield CD
    Curr Opin Hematol; 2007 Mar; 14(2):106-14. PubMed ID: 17255787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid receptors, hematopoiesis and leukemogenesis.
    Collins SJ
    Curr Opin Hematol; 2008 Jul; 15(4):346-51. PubMed ID: 18536573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia.
    Deshpande AJ; Cusan M; Rawat VP; Reuter H; Krause A; Pott C; Quintanilla-Martinez L; Kakadia P; Kuchenbauer F; Ahmed F; Delabesse E; Hahn M; Lichter P; Kneba M; Hiddemann W; Macintyre E; Mecucci C; Ludwig WD; Humphries RK; Bohlander SK; Feuring-Buske M; Buske C
    Cancer Cell; 2006 Nov; 10(5):363-74. PubMed ID: 17097559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of new prognostic markers in treatment decisions in acute myeloid leukemia.
    Schlenk RF; Döhner K
    Curr Opin Hematol; 2009 Mar; 16(2):98-104. PubMed ID: 19468271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the molecular pathogenesis of myeloid malignancies.
    Haferlach T; Bacher U; Haferlach C; Kern W; Schnittger S
    Curr Opin Hematol; 2007 Mar; 14(2):90-7. PubMed ID: 17255785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of acute myeloid leukemia and its impact on treatment.
    Frankfurt O; Licht JD; Tallman MS
    Curr Opin Oncol; 2007 Nov; 19(6):635-49. PubMed ID: 17906465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.